SIGNPATH PHARMA, INC. Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31)
SIGNPATH PHARMA, INC. had Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) of $13.86 million as of 2015-03-31, per its 10-Q filed 2015-05-20.
Discontinued › Notes
us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage · last filed 2015-05-20
- 2015-03-31: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $13.86M.
- 2014-09-30: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $12.81M.
- 2014-06-30: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $11.83M.
- 2014-03-31: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $10.87M.
| Period end | Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) |
|---|---|
| 2015-03-31 | $13.86M 10-Q · filed 2015-05-20 |
| 2014-09-30 | $12.81M 10-Q · filed 2014-11-14 |
| 2014-06-30 | $11.83M 10-Q · filed 2014-08-18 |
| 2014-03-31 | $10.87M 10-Q · filed 2014-05-14 |
| 2013-12-31 | $10.67M 10-Q · filed 2014-08-18 |
| 2013-09-30 | $10.38M 10-Q · filed 2013-11-14 |
| 2013-06-30 | $9.89M 10-Q · filed 2013-08-14 |
| 2013-03-31 | $9.48M 10-Q · filed 2013-05-15 |
| 2012-12-31 | $8.71M 10-K · filed 2014-03-31 |
| 2012-09-30 | $8.20M 10-Q · filed 2012-11-14 |
| 2012-06-30 | $8.05M 10-Q/A · filed 2012-09-13 |
| 2012-03-31 | $7.74M 10-Q · filed 2012-05-21 |
| 2011-12-31 | $7.40M 10-K · filed 2013-04-01 |
| 2011-09-30 | $6.45M 10-Q · filed 2011-11-21 |
| 2011-06-30 | $6.04M 10-Q · filed 2011-08-10 |
| 2010-12-31 | $5.12M 10-K · filed 2012-03-30 |